Evidence map›Paper›PMID 40488439›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Circulating Tumor Cells Shed Shearosome Extracellular Vesicles in Capillary Bifurcations That Activate Endothelial and Immune Cells.

Angelos Vrynas, Salime Bazban-Shotorbani, Sara Arfan, Karishma Satia, Brian Cunningham, Gauhar Sagindykova, Mymuna Ashna, Aoyu Zhang, Diana Visan, Aisher Chen and 7 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Angelos VrynasDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.
Salime Bazban-ShotorbaniDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.
Sara ArfanDivision of Cancer Biology, The Institute of Cancer Research, London, SM2 5NG, United Kingdom.
Karishma SatiaCancer Research UK Lung Cancer Centre of Excellence, Manchester, M13 9PL, United Kingdom.
Brian CunninghamDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.
Gauhar SagindykovaDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.
Mymuna AshnaDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.
Aoyu ZhangDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.
Diana VisanDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.
Aisher ChenDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.
Teige Matthews-PalmerDivision of Structural Biology, The Institute of Cancer Research, London, SW7 3RP, United Kingdom.
Mathew CarterCancer Research UK National Biomarker Centre, University of Manchester, Manchester, M13 9PL, United Kingdom.
Fiona BlackhallCancer Research UK Lung Cancer Centre of Excellence, Manchester, M13 9PL, United Kingdom.
Kathryn L SimpsonCancer Research UK National Biomarker Centre, University of Manchester, Manchester, M13 9PL, United Kingdom.
Caroline DiveCancer Research UK National Biomarker Centre, University of Manchester, Manchester, M13 9PL, United Kingdom.
Paul HuangDivision of Cancer Biology, The Institute of Cancer Research, London, SM2 5NG, United Kingdom.
Sam H AuDepartment of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.ORCID https://orcid.org/0000-0003-3411-3145

Funding

Coordinating center for the NCI small cell lung cancer research consortiumU24CA213274 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Lauren Averett Byers, JOHN D. MINNA · 2017 to 2026
$12.9M
Novel therapeutic development for small cell lung cancerR35CA263816 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Charles M. Rudin · 2021 to 2026
$6.3M
Cancer Research UK CTRQQR-2021∖100010Christie Charitable FundCore Cancer Research UK funding to the CRUK Manchester Institute A27412CRUK Lung Cancer Centre of Excellence A20465CRUK Manchester Institute C5759/A12328CRUK Multidisciplinary Award DRCMDPA∖100008CRUK National Biomarker Centre :Medical Research Council MR/Y000609/1NCI NIH HHS R35 CA263816NCI NIH HHS U24 CA213274NCI NIH HHS U24CA213274
6 · The paper itself

Abstract

Circulating tumor cells (CTCs) and their clusters are the cellular drivers of metastasis. This study uses microfluidic models mimicking human capillary bifurcations to better understand how these cells interact with capillary beds. Patient CTCs, CTC-derived explant cells, and numerous cancer cell lines shed nuclei-free fragments in a cell size- and bifurcation-dependent manner. These shedding events, which reduces cell sizes up to 61%, facilitate CTC transit through bifurcations. The shed fragments are a novel subclass of large extracellular vesicles (LEVs) that we name "shearosomes" based on their requirement of shear stress for their biogenesis, and whose proteome is associated with immune-related pathways. Shearosomes exhibit functions that are characteristic of previously identified extracellular vesicles (EVs), including cell-directed internalization by endothelial and immune cells, and intercellular communication capabilities such as disruption of endothelial barrier integrity, polarization of monocytes toward M2 tumor-promoting macrophages, and mediating interactions between endothelial and immune cells. These findings suggest that CTCs shed shearosomes within capillary beds that affect cells implicated in the metastatic cascade.

Indexed as

CapillariesEndothelial CellsExtracellular VesiclesNeoplastic Cells, CirculatingCell CommunicationCell Line, TumorHumanscancer metastasiscirculating tumor cellslarge extracellular vesiclesmicrofluidicspremetastatic niche

Identifiers

PMID40488439
PMCPMC12376581

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.